Citations

Clear

62 citation(s) found for "Allison, Thomas".

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Basch, Ethan , Deal, Allison M. , Scher, Howard I. , Hudis, Clifford A. , Sabbatini, Paul , Rogak, Lauren J. , Dueck, Amylou C. , Atkinson, Thomas M. , Chou, Joanne F. , Dulko, Dorothy , Sit, Laura , Leahy, Allison Barz , Novotny, Paul J. , Fruscione, M. , Sloan, Jeff A. , Schrag, Deborah , Kris, Mark G, Rogak, Lauren , Bennett, Antonia V. , Barz, Allison, Novotny, Paul, Fruscione, Michael, Dueck, A. C. , Basch, Ethan , Deal, Allison , Kris, Mark G. , Bennett, Antonia V , Schrag, Deborah , Leahy, Allison B

Mayo Clinic

Journal of Clinical Oncology | December 8, 2015 | Volume: 34 | Issue: 6 | Pages: 557-565

10.1200/jco.2015.63.0830 | PMID 26644527 Get It

Purpose There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion Clinical benefits were associated with symptom self-reporting during cancer care.
Impact of Utilizing a Women-Based Formula for Determining Adequacy of the Chronotropic Response During Exercise Treadmill Testing
Gulati, Martha , Pack, Quinn R. , Barr, Laurie, Allison, Thomas G. , Abdelmoneim, Sahar S. , Mulvagh, Sharon L. , Scott, Christopher G.

Mayo Clinic

Journal of Women's Health | March 11, 2015 | Volume: 24 | Issue: 3 | Pages: 174-181

10.1089/jwh.2014.4935 | PMID 25761214 Get It

Background: A women-based formula for calculation of age-predicted maximum heart rate [age-predicted maximum heart rate=206−(0.88×age)] was established in asymptomatic volunteer women undergoing treadmill exercise tolerance testing (ETT). We sought to perform a comparison of the performance of this women-based formula for prediction of peak heart rate to the traditional formula [220−age] and our own database-generated prediction formula in a large database of women undergoing ETT. Methods: We performed a retrospective analysis of all consecutive women who underwent symptom-limited Bruce protocol ETT at the Mayo Clinic from 1994 to 2010. Women with known cardiovascular disease or those using beta blockers, calcium channel blockers, or digitalis were excluded. Separate analyses were performed according to symptomatic status. Results: The study included 11,029 women (89.4% Caucasian) with a mean age 52±12 years; 3,632 (33%) were referred specifically for evaluation of symptoms. Age-predicted maximum heart rate calculated by the traditional formula was achieved by 49.7% of women versus 69.9% by the women-based formula with most of the underestimation observed in older women. Average absolute deviation between achieved and predicted peak heart rate (HR) was 10.85±9.18 bpm for traditional versus 11.98±9.00 for women-based formulas (dependent t =−16.64, p <0.0001). The linear regression line calculated from our population [HR=201−(0.67×age)] was closer to the women-based formula, both in terms of intercept and slope than the traditional formula. Peak HR was shown to be slightly affected (−2.5 bpm) by symptom status at referral, whereas smoking and diabetes more significantly reduced achieved peak HR. Conclusions: The women-based formula underestimated peak HR, especially in older women, but was observed to be closer in both intercept and slope to the regression line determined from our study in this large population of female patients. These sex-unique observations should be taken into account when determining adequacy and targets for ETT in women.
Cardiorespiratory Response to Exercise before and after Pulmonary Valve Replacement in Patients with Repaired Tetralogy of Fallot: A Retrospective Study and Systematic Review of the Literature
Sabaté-Rotés, Anna , Johnson, Jonathan N. , Burkhart, Harold M. , Eidem, Benjamin W., Allison, Thomas G. , Driscoll, David J.

Mayo Clinic

Congenital Heart Disease | August 4, 2014 | Volume: 10 | Issue: 3 | Pages: 263-270

10.1111/chd.12207 | PMID 25088332 Get It

Sport Modality Affects Bradycardia Level and Its Mechanisms of Control in Professional Athletes
Azevedo, L.S. , Perlingeiro, Patrícia de Sá, Allison, Thomas G. , Hachul, Denise , Gomes‐Santos, Igor L. , Brum, Patrı́cia C. , Negrão, Carlos Eduardo , Matos, Luciana Diniz Nagem Janot de

Mayo Clinic

International Journal of Sports Medicine | July 10, 2014 | Volume: 35 | Issue: 11 | Pages: e3-e3

10.1055/s-0034-1384589 | PMID 25009963 Get It

Sport Modality Affects Bradycardia Level and Its Mechanisms of Control in Professional Athletes
Azevedo, L. , Perlingeiro, Patrícia de Sá, Hachul, Denise , Gomes‐Santos, Igor L. , Allison, Thomas G. , Negrão, Carlos Eduardo , Matos, Luciana Diniz Nagem Janot de , Brum, Patrı́cia C.

Mayo Clinic

International Journal of Sports Medicine | June 2, 2014 | Volume: 35 | Issue: 11 | Pages: 954-959

10.1055/s-0033-1364024 | PMID 24886917 Get It

Cardiopulmonary Fitness and Heart Rate Recovery as Predictors of Mortality in a Referral Population
Dhoble, Abhijeet , Lahr, Brian D. , Allison, Thomas G. , Kopecky, Stephen L.

Mayo Clinic

Journal of the American Heart Association | March 25, 2014 | Volume: 3 | Issue: 2 | Pages: No page available

10.1161/jaha.113.000559 | PMID 24663334 Get It

Background Exercise testing provides valuable information in addition to ST ‐segment changes. The present study evaluated the associations among exercise test parameters and all‐cause mortality in a referral population. Methods and Results We examined conventional cardiovascular risk factors and exercise test parameters in 6546 individuals (mean age 49 years, 58% men) with no known cardiovascular disease who were referred to our clinic for exercise stress testing between 1993 and 2003. The association of exercise parameters with mortality was assessed during a follow‐up of 8.1±3.7 years. A total of 285 patients died during the follow‐up period. Adjusting for age and sex, the variables associated with mortality were: smoking, diabetes, functional aerobic capacity ( FAC ), heart rate recovery ( HRR ), chronotropic incompetence, and angina during the exercise. Adjusting for cardiovascular risk factors (diabetes, smoking, body mass index, blood pressure, serum total, HDL , LDL cholesterol, and triglycerides) and other exercise variables in a multivariable model, the only exercise parameters independently associated with mortality were lower FAC (adjusted hazard ratio [ HR ] per 10% decrease in FAC , 1.21; 95% confidence interval [ CI ], 1.13 to 1.29; P <0.001), and abnormal HRR , defined as failure to decrease heart rate by 12 beats at 1 minute recovery (adjusted HR per 1‐beat decrease, 1.05; 95% CI , 1.03 to 1.07; P <0.001). The additive effects of FAC and HRR on mortality were also highly significant when considered as categorical variables. Conclusion In this cohort of patients with no known cardiovascular disease who were referred for exercise electrocardiography, FAC and HRR were independently associated with all‐cause mortality.
Go Red for Women Cardiovascular Health–Screening Evaluation: The Dichotomy Between Awareness and Perception of Cardiovascular Risk in the Community
Kling, Juliana M. , Miller, Virginia , Mankad, Rekha , Wilansky, Susan , Wu, Qing , Zais, Teresa, Zarling, Kathleen K., Allison, Thomas G. , Mulvagh, Sharon L. , Kling, Juliana M , Mankad, Rekha

Mayo Clinic

Journal of Women's Health | March 12, 2013 | Volume: 22 | Issue: 3 | Pages: 210-218

10.1089/jwh.2012.3744 | PMID 23480314 Get It

Background: Cardiovascular (CV) disease is the leading cause of death in U.S. women. Although women are becoming more aware of CV disease, there remains a dichotomy between awareness and perceived risk. We sought to characterize this dichotomy in women attracted to a CV health–screening event, in order to improve strategies to reduce CV risk. Methods: During CV health events held in Rochester, Minnesota, from 2007 through 2011, 294 women underwent screening for blood chemistry, body mass index, and blood pressure. Participants also completed surveys about knowledge of CV disease, risk factors, and perceived risk. Risk level was determined from the 2011 American Heart Association Effectiveness-Based Guidelines for Women. Results: Among participants (age, mean [standard deviation], 53 [15.3] years; white, 98%), 99% were aware that CV disease is the leading cause of death in women. Almost half (47%) perceived themselves to be at personal risk, although 65% were determined to be “at risk” and 12% to be at “high risk” according to guidelines, while 22% were uncategorized. Of the 228 participants “at risk” or “high risk,” 48% and 21%, respectively, did not perceive themselves to be at any risk. Conclusions : Women attracted to CV health events were aware that CV disease is the leading cause of death for women. However, the magnitude of awareness did not directly translate into perception or understanding of actual personal risk. To decrease the rate of CV disease in women, continued efforts are needed to personalize the importance of, and the methods for reducing, CV risk factors.
The Safety of Cardiopulmonary Exercise Testing in a Population With High-Risk Cardiovascular Diseases
Skalski, Joseph H. , Allison, Thomas G. , Miller, Todd D.

Mayo Clinic

Circulation | October 24, 2012 | Volume: 126 | Issue: 21 | Pages: 2465-2472

10.1161/circulationaha.112.110460 | PMID 23091065 Get It

Background— Cardiopulmonary exercise testing (CPX) with measurement of peak oxygen uptake (V o 2 ) is a powerful test for assessment and quantification of functional impairment resulting from cardiovascular disease. The safety of CPX has been established in patients with coronary artery disease and congestive heart failure, but clinical use of CPX in other cardiac diseases has been limited, in part because of a paucity of safety data. This study investigates the safety of CPX in a heterogeneous cohort of patients with a wide variety of underlying high-risk cardiac diagnoses. Methods and Results— This single-center retrospective review examined 5060 CPX studies performed in 4250 unique patients, including 1748 (35%) female subjects and 686 (14%) subjects aged ≥75 years. The primary end point was major adverse event during stress testing. The study population included patients with a variety of high-risk cardiac diseases, including congestive heart failure (n=1289, 25.5%), hypertrophic cardiomyopathy (n=598, 11.8%), pulmonary hypertension (n=194, 3.8%), and aortic stenosis (n=212, 4.2%). This patient population generally had severe functional impairment, including 1192 (24%) patients with peak V o 2 <14 mL/kg/min. Eight adverse events occurred during CPX, for an adverse event rate of 0.16%. The most common adverse event (n=6) was sustained ventricular tachycardia. There were no fatal events. Conclusions— CPX is generally a safe procedure, even in a population with underlying high-risk cardiovascular diagnoses.
Deconditioning in patients with orthostatic intolerance
Parsaik, Ajay K. , Allison, Thomas G. , Sletten, David M., Benarroch, Eduardo E. , Low, Phillip A. , Sandroni, Paola , Singer, Wolfgang , Joyner, Michael J.

Mayo Clinic

Neurology | September 20, 2012 | Volume: 79 | Issue: 14 | Pages: 1435-1439

10.1212/wnl.0b013e31826d5f95 | PMID 22993288 Get It

Improving Weight Loss in Cardiac Rehabilitation
Allison, Thomas G.

Mayo Clinic

Circulation | May 12, 2009 | Volume: 119 | Issue: 20 | Pages: 2650-2652

10.1161/circulationaha.109.860569 | PMID 19433752 Get It